Biotech Values

[DewDiligence]

ZMH issues 2014 guidance:

http://finance.yahoo.com/news/zimmer-holdings-inc-reports-fourth-123000035.html

The Company expects full-year revenues for 2014 to increase between 3.0% and 5.0% on a constant currency basis. The Company estimates that foreign currency translation will decrease revenues by approximately 0.5% for the full year 2014, resulting in reported revenue growth between 2.5% and 4.5%. Full-year 2014 diluted earnings per share are projected to be in a range of $5.00 to $5.20 on a reported basis [GAAP] and $6.10 to $6.30 on an adjusted basis [non-GAAP].